Cargando…
Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities
Purpose: To establish a clinically applicable genomic clustering system, we investigated the interactive landscape of driver mutations in intrahepatic cholangiocarcinoma (ICC). Methods: The genomic data of 1481 ICCs from diverse populations was analyzed to investigate the pair-wise co-occurrences or...
Autores principales: | Wang, Xiang-Yu, Zhu, Wen-Wei, Wang, Zheng, Huang, Jian-Bo, Wang, Sheng-Hao, Bai, Fu-Mao, Li, Tian-En, Zhu, Ying, Zhao, Jing, Yang, Xin, Lu, Lu, Zhang, Ju-Bo, Jia, Hu-Liang, Dong, Qiong-Zhu, Chen, Jin-Hong, Andersen, Jesper B., Ye, Dan, Qin, Lun-Xiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690927/ https://www.ncbi.nlm.nih.gov/pubmed/34987644 http://dx.doi.org/10.7150/thno.63417 |
Ejemplares similares
-
Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities
por: Lin, Jian, et al.
Publicado: (2022) -
Proteome Landscapes of Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Yi, Xiao, et al.
Publicado: (2023) -
Development and validation of a mutation-annotated prognostic score for intrahepatic cholangiocarcinoma after resection: a retrospective cohort study
por: Wang, Xiang-Yu, et al.
Publicado: (2023) -
Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance
por: Komuta, Mina
Publicado: (2022) -
Benefit of everolimus in treatment of an intrahepatic cholangiocarcinoma patient with a PIK3CA mutation
por: Bian, Ji-Lai, et al.
Publicado: (2017)